Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$941M |
| 2 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$933M |
| 3 |
Dimensional Emerging Markets High Profitability ETF
DEHP
|
+$467M |
| 4 |
Exxon Mobil
XOM
|
+$386M |
| 5 |
Warner Bros
WBD
|
+$260M |
Top Sells
| 1 |
Dimensional National Municipal Bond ETF
DFNM
|
+$654M |
| 2 |
AT&T
T
|
+$372M |
| 3 |
Amazon
AMZN
|
+$350M |
| 4 |
Dimensional US High Profitability ETF
DUHP
|
+$263M |
| 5 |
CERN
Cerner Corp
CERN
|
+$212M |
Sector Composition
| 1 | Financials | 16.93% |
| 2 | Technology | 15.17% |
| 3 | Industrials | 11.99% |
| 4 | Healthcare | 11.63% |
| 5 | Consumer Discretionary | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Harvard Bioscience
HBIO
$19.7M
| $6.76M | ﹤0.01% |
1,877,842
-208
| -0% | -$749 |
|
2352
Protagonist Therapeutics
PTGX
$3.66B
| $6.75M | ﹤0.01% |
852,775
-10,117
| -1% | -$80K |
|
2353
MVB Financial
MVBF
$305M
| $6.74M | ﹤0.01% |
216,644
+34,148
| +19% | +$1.06M |
|
|
FINV
2354
FinVolution Group
FINV
$1.9B
| $6.73M | ﹤0.01% |
1,417,488
+259,083
| +22% | +$1.23M |
|
|
PFSW
2355
DELISTED
PFSweb, Inc.
PFSW
| $6.72M | ﹤0.01% |
571,151
+45,779
| +9% | +$538K |
|
2356
Information Services Group
III
$253M
| $6.71M | ﹤0.01% |
993,038
+54,791
| +6% | +$370K |
|
2357
Bausch Health
BHC
$2.68B
| $6.7M | ﹤0.01% |
801,821
+116,872
| +17% | +$977K |
|
2358
Willdan Group
WLDN
$1.48B
| $6.7M | ﹤0.01% |
242,917
+23,299
| +11% | +$642K |
|
2359
Ascent Industries
ACNT
$119M
| $6.69M | ﹤0.01% |
475,745
+12,154
| +3% | +$171K |
|
2360
Arcutis Biotherapeutics
ARQT
$2.07B
| $6.66M | ﹤0.01% |
312,608
+85,225
| +37% | +$1.82M |
|
|
TBCH
2361
Turtle Beach Corporation Common Stock
TBCH
$299M
| $6.65M | ﹤0.01% |
543,659
+144,223
| +36% | +$1.76M |
|
|
IVAC
2362
DELISTED
Intevac Inc
IVAC
| $6.63M | ﹤0.01% |
1,369,838
+39,727
| +3% | +$192K |
|
2363
Fate Therapeutics
FATE
$111M
| $6.62M | ﹤0.01% |
267,166
-121,950
| -31% | -$3.02M |
|
2364
Nature's Sunshine
NATR
$299M
| $6.62M | ﹤0.01% |
619,976
+59,382
| +11% | +$634K |
|
2365
OR Royalties Inc.
OR
$6.76B
| $6.6M | ﹤0.01% |
653,097
+319,104
| +96% | +$3.22M |
|
2366
First Northwest Bancorp
FNWB
$67.1M
| $6.6M | ﹤0.01% |
422,801
+7,399
| +2% | +$115K |
|
2367
Mitek Systems
MITK
$467M
| $6.6M | ﹤0.01% |
713,831
-44,074
| -6% | -$407K |
|
2368
Relay Therapeutics
RLAY
$688M
| $6.6M | ﹤0.01% |
393,791
+335,925
| +581% | +$5.63M |
|
2369
AstroNova
ALOT
$76.1M
| $6.58M | ﹤0.01% |
549,451
+5,524
| +1% | +$66.2K |
|
|
PWOD
2370
DELISTED
Penns Woods Bancorp
PWOD
| $6.58M | ﹤0.01% |
284,780
+3,947
| +1% | +$91.1K |
|
2371
KT
KT
$9.52B
| $6.56M | ﹤0.01% |
469,553
+7,130
| +2% | +$99.5K |
|
2372
Escalade
ESCA
$171M
| $6.49M | ﹤0.01% |
499,659
+21,550
| +5% | +$280K |
|
2373
LCNB Corp
LCNB
$223M
| $6.48M | ﹤0.01% |
433,292
+30,553
| +8% | +$457K |
|
2374
Parke Bancorp
PKBK
$266M
| $6.47M | ﹤0.01% |
308,889
+24,511
| +9% | +$514K |
|
|
RAD
2375
DELISTED
Rite Aid Corporation
RAD
| $6.46M | ﹤0.01% |
958,866
-791,278
| -45% | -$5.33M |
|